These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21734073)

  • 21. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deletion of STAT-1 pancreatic islets protects against streptozotocin-induced diabetes and early graft failure but not against late rejection.
    Callewaert HI; Gysemans CA; Ladrière L; D'Hertog W; Hagenbrock J; Overbergh L; Eizirik DL; Mathieu C
    Diabetes; 2007 Aug; 56(8):2169-73. PubMed ID: 17473223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.
    Matsumoto M; Yagi H; Kunimoto K; Kawaguchi J; Makino S; Harada M
    Cell Immunol; 1993 Apr; 148(1):189-97. PubMed ID: 8098666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dendritic cells and macrophages are the first and major producers of TNF-alpha in pancreatic islets in the nonobese diabetic mouse.
    Dahlén E; Dawe K; Ohlsson L; Hedlund G
    J Immunol; 1998 Apr; 160(7):3585-93. PubMed ID: 9531322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
    Trembleau S; Penna G; Gregori S; Chapman HD; Serreze DV; Magram J; Adorini L
    J Immunol; 1999 Sep; 163(5):2960-8. PubMed ID: 10453045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta cells cannot directly prime diabetogenic CD8 T cells in nonobese diabetic mice.
    de Jersey J; Snelgrove SL; Palmer SE; Teteris SA; Mullbacher A; Miller JF; Slattery RM
    Proc Natl Acad Sci U S A; 2007 Jan; 104(4):1295-300. PubMed ID: 17229843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transgenic expression of decoy receptor 3 protects islets from spontaneous and chemical-induced autoimmune destruction in nonobese diabetic mice.
    Sung HH; Juang JH; Lin YC; Kuo CH; Hung JT; Chen A; Chang DM; Chang SY; Hsieh SL; Sytwu HK
    J Exp Med; 2004 Apr; 199(8):1143-51. PubMed ID: 15078896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-1-antitrypsin for the improvement of autoimmunity and allograft rejection in beta cell transplantation.
    Ye J; Liao YT; Jian YQ; Zhang XD; Wei P; Qi H; Deng CY; Li FR
    Immunol Lett; 2013 Feb; 150(1-2):61-8. PubMed ID: 23333354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transgenic tumor necrosis factor (TNF)-alpha production in pancreatic islets leads to insulitis, not diabetes. Distinct patterns of inflammation in TNF-alpha and TNF-beta transgenic mice.
    Picarella DE; Kratz A; Li CB; Ruddle NH; Flavell RA
    J Immunol; 1993 May; 150(9):4136-50. PubMed ID: 7682590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.
    Tritt M; Sgouroudis E; d'Hennezel E; Albanese A; Piccirillo CA
    Diabetes; 2008 Jan; 57(1):113-23. PubMed ID: 17928397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice.
    Han HS; Jun HS; Utsugi T; Yoon JW
    J Autoimmun; 1996 Jun; 9(3):331-9. PubMed ID: 8816968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.
    Cameron MJ; Arreaza GA; Zucker P; Chensue SW; Strieter RM; Chakrabarti S; Delovitch TL
    J Immunol; 1997 Nov; 159(10):4686-92. PubMed ID: 9366391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of new-onset diabetes through modulating inflammation and stimulating beta-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor.
    Tian L; Gao J; Hao J; Zhang Y; Yi H; O'Brien TD; Sorenson R; Luo J; Guo Z
    Endocrinology; 2010 Jul; 151(7):3049-60. PubMed ID: 20444936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo effects of cytokines on pancreatic beta-cells in models of type I diabetes dependent on CD4(+) T lymphocytes.
    Angstetra E; Graham KL; Emmett S; Dudek NL; Darwiche R; Ayala-Perez R; Allison J; Santamaria P; Kay TW; Thomas HE
    Immunol Cell Biol; 2009 Feb; 87(2):178-85. PubMed ID: 19015667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha.
    Pakala SV; Chivetta M; Kelly CB; Katz JD
    J Exp Med; 1999 Apr; 189(7):1053-62. PubMed ID: 10190896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting pre-ligand assembly domain of TNFR1 ameliorates autoimmune diseases - an unrevealed role in downregulation of Th17 cells.
    Wang YL; Chou FC; Chen SJ; Lin SH; Chang DM; Sytwu HK
    J Autoimmun; 2011 Nov; 37(3):160-70. PubMed ID: 21689905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice.
    Wu AJ; Hua H; Munson SH; McDevitt HO
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12287-92. PubMed ID: 12221281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-TNF rescue CD4+Foxp3+ regulatory T cells in patients with type 1 diabetes from effects mediated by TNF.
    Ryba M; Marek N; Hak Ł; Rybarczyk-Kapturska K; Myśliwiec M; Trzonkowski P; Myśliwska J
    Cytokine; 2011 Sep; 55(3):353-61. PubMed ID: 21641234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [TNF-α, diabetes type 1 and regulatory T cells].
    Ryba M; Myśliwska J
    Pediatr Endocrinol Diabetes Metab; 2010; 16(4):295-300. PubMed ID: 21447272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 20-Mb region of chromosome 4 controls TNF-alpha-mediated CD8+ T cell aggression toward beta cells in type 1 diabetes.
    Chamberlain G; Wållberg M; Rainbow D; Hunter K; Wicker LS; Green EA
    J Immunol; 2006 Oct; 177(8):5105-14. PubMed ID: 17015694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.